Muthoot FinCorp raises Rs. 200 crore via private placement of NCDs from State Bank of India

-

 Muthoot FinCorp raises Rs. 200 crore via private placement of NCDs from State Bank of India

 


Trivandrum, December 26, 2023: Muthoot FinCorp Limited (“Company”), the flagship company of 136-year-old Muthoot Pappachan Group (Muthoot Blue) has announced Rs. 200 crore investment by State Bank of India, country’s largest bank, in the NCDs under private placement with a face value of Rs. 1lakh for each NCD.

The maturity/tenure options of this issue is five years with half yearly being the frequency of the interest payment. The secured issued NCDs is rated as AA-/ Stable by CRISIL and listed on the debt market segment of BSE.

 

“Trust and integrity are core to Muthoot FinCorp. We are happy that India’s largest bank has invested in the NCDs issued and the proceeds of this will be utilised for onward lending, business operations and further expansion and growth plan. We will strive further to bring in innovative products and services to meet the lifecycle requirements of our customers. Today, I’d like to thank our millions of customers for bestowing their trust and continuing to support us throughout these years helping us meet the needs of the common man and enabling financial inclusion,” said Mr. Shaji Varghese, CEO – Muthoot FinCorp Limited.

Muthoot FinCorp with its over 3600 branches across India works towards the goal of financial inclusion of every household in the country. Some of our offerings include – Gold Loans, Vyapar Mitra Business Loans, Two-wheeler loans, Used car loans, Home Loans, Loan Against Property, Domestic & International Money Transfer, Foreign exchange, Insurance products & services, Wealth Management services, and many more.

Comments

Post a Comment

Popular posts from this blog

Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy

-
  Indegene acquires Trilogy Writing & Consulting GmbH,  a medical writing consultancy   India, March 27, 2024:  Indegene, a  digital-first, life sciences commercialization company , announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. The acquisition by Indegene Ireland, a subsidiary of Indegene Limited, augments Indegene’s depth of clinical and regulatory writing expertise for market authorization applications globally.   Trilogy Writing & Consulting is a Germany, UK, and US-based, medical writing consultancy with know-how in the development and delivery of clinical, regulatory, safety, and medical content. It applies its expertise and unique approaches to deliver quality medical writing output. Trilogy has a proven track record of more than 22 years of providing medical writing ser...
Read more

After Abida Parveen & Atif Aslam's magical performance, Next is Enrique Iglesias who is all set to perform in UAE

-
Image
  After Abida Parveen & Atif Aslam's magical performance, Next is Enrique Iglesias who is all set to perform in UAE After the massive success of the unprecedented and unique collaboration named ‘Symphony of Stars,’ featuring Abida Parveen and Atif Aslam together recently, the leading lifestyle management company Blu Blood is all set to bring the global pop sensation Enrique Iglesias to the Coca-Cola Arena in Dubai on September 13th, 2024. When the legendary music icons Abida Parveen and Atif Aslam shared the stage, the audience witnessed something truly breathtaking and unforgettable. The concert stood out from the ordinary, as fans went wild on social media, sharing numerous posts detailing their once-in-a-lifetime experiences and concert clips that touched the hearts of many, quickly going viral. It has entertained fans across the country, and now Blu Blood promises to deliver the same epic musical extravaganza with the Latin megastar Enrique Iglesias for the very first time....
Read more